UCHL3 and rhabdomyosarcoma: Inhibiting the proteasome using MG132 led to marked enrichment of K48-ubiquitylated TDP1 in control cells but no impact in rhabdomyosarcoma cells, due to high UCHL3 levels (Figure 3C).